{
    "Trade/Device Name(s)": [
        "RAMP\u00ae Influenza A/B Assay"
    ],
    "Submitter Information": "Response Biomedical Corporation",
    "510(k) Number": "K071591",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062109"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "April 16, 2008",
    "Summary Letter Received Date": "April 7, 2008",
    "Submission Date": "April 3, 2008",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A nucleoprotein antigen",
        "Influenza B nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal wash",
        "Nasal aspirate",
        "Nasopharyngeal aspirate",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Foam swab",
        "Polyester swab",
        "Rayon swab",
        "Nylon swab",
        "Copan Universal Transport Media",
        "Remel M4 Media",
        "Remel M4-RT Media",
        "Remel M5 Media",
        "Starplex Transport Media",
        "Phosphate Buffered Saline"
    ],
    "Instrument(s)/Platform(s)": [
        "RAMP 200"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Fluorescent-dyed particle immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic testing",
        "Antigen detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for RAMP Influenza A/B Assay, a rapid qualitative immunochromatographic test for detecting influenza A and B nucleoprotein antigens in upper respiratory tract specimens.",
    "Indications for Use Summary": "Qualitative immunochromatographic assay for identifying Influenza A and B nucleoprotein antigens in nasal wash, nasal aspirate, nasopharyngeal aspirate, and nasopharyngeal swab specimens from symptomatic patients to aid rapid differential diagnosis of influenza infection; negative tests are presumptive and should be confirmed by cell culture.",
    "fda_folder": "Microbiology"
}